VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F900. A total of 9 filers reported holding VERTEX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $593 | +280.1% | 59,600 | +1092.0% | 0.01% | +600.0% |
| Q2 2023 | $156 | -86.6% | 5,000 | -94.3% | 0.00% | -92.9% |
| Q1 2023 | $1,167 | +19350.0% | 88,000 | +780.0% | 0.01% | – |
| Q4 2022 | $6 | -100.0% | 10,000 | +25.0% | 0.00% | -100.0% |
| Q3 2022 | $281,000 | -41.7% | 8,000 | -38.5% | 0.00% | -40.0% |
| Q2 2022 | $482,000 | -84.1% | 13,000 | -87.1% | 0.01% | -77.3% |
| Q1 2022 | $3,032,000 | +338.2% | 100,500 | +570.0% | 0.02% | +450.0% |
| Q4 2021 | $692,000 | +1135.7% | 15,000 | -62.5% | 0.00% | – |
| Q3 2020 | $56,000 | – | 40,000 | +233.3% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2016 | $11,000 | -35.3% | 12,000 | 0.0% | 0.00% | – |
| Q2 2016 | $17,000 | -34.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2016 | $26,000 | -90.1% | 12,000 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $263,000 | +87.9% | 12,000 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $140,000 | -51.7% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $290,000 | +5.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $276,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WINTRUST INVESTMENTS LLC | 2,700 | $492,000 | 0.05% |
| GROUP ONE TRADING, L.P. | 153,800 | $40,137,000 | 0.04% |
| SG Americas Securities, LLC | 100,500 | $3,032,000 | 0.02% |
| SIMPLEX TRADING, LLC | 69,500 | $18,137,000 | 0.02% |
| IMC-Chicago, LLC | 18,200 | $4,750,000 | 0.01% |
| HRT FINANCIAL LP | 900 | $234,000 | 0.00% |
| Allianz Asset Management GmbH | 800 | $209,000 | 0.00% |
| JPMORGAN CHASE & CO | 15,000 | $3,915,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |